Amedisys (NASDAQ:AMED) was upgraded from Underperform to Neutral at RW Baird today. The stock closed yesterday at $10.31 on volume of 976,000 shares, above average daily volume of 563,000.
Amedisys (NASDAQ:AMED) was upgraded from Neutral to Outperform at RW Baird today. The stock closed yesterday at $10.17 on volume of 478,000 shares, below average daily volume of 559,000.
Below are the three companies in the Health Care Services industry with the lowest EBITDA Growth (next year estimate vs. LTM). EBITDA Growth can be valuable in predicting future cash flow generation and earnings power.
The price of Amedisys shares has slipped to $10.61 (a 21.0% change) on heavy trading volume. Today's volume of 1.8 million shares tops the average 30-day volume of 408,000 shares. Spikes in volume can validate a breakout or signify a potential...
Below are the three companies in the Health Care Services industry with the lowest Revenue Per Employee (RPE). Analysts use RPE as a measure to compare the productivity of companies in the same industry.
SmarTrend identified an Uptrend for Amedisys (NASDAQ:AMED) on February 3rd, 2012 at $11.79. In approximately 3 months, Amedisys has returned 22.73% as of today's recent price of $14.47.
SmarTrend identified an Uptrend for Amedisys (NASDAQ:AMED) on February 3rd, 2012 at $11.79. In approximately 3 months, Amedisys has returned 26.38% as of today's recent price of $14.90.
Below are the three companies in the Health Care Services industry with the highest betas. Higher-beta stocks mean greater volatility and are therefore generally considered to be riskier but also may provide the potential for higher returns....